Attached files
| file | filename |
|---|---|
| 8-K - MedPro Safety Products, Inc. | v220806_8k.htm |
This release includes forward-looking statements based upon current expectations of the management of MedPro Safety Products, Inc. that involve risks and uncertainties, such as plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward- looking statements as a result of a number of factors, including our ability to identify and acquire medical safety device safety technologies with product development potential; our ability to successfully develop and bring products to market, including obtaining regulatory approvals; our ability to successfully increase sales of our products; our ability to obtain additional financing on satisfactory terms; our ability to attract and retain qualified employees; and governmental regulation associated with the medical safety products industry. Words such as "anticipate," "estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions are used to identify forward-looking statements. We refer you to the more detailed discussion of risks and uncertainties under "Risk Factors" in our Annual Report on Form 10-K and our other reports on file with the Securities and Exchange Commission.
More than 1 million needlesticks annually Each needlestick costs approximately $3,000 Current solutions do not fully address problem
Hepatitis C Hepatitis B HIV Bloodborne Pathogen Microorganisms present in human blood that can cause disease in humans Over 20 OSHA others
OSHA, CDC, FDA require employers and providers to evaluate sharps with engineered sharps injury protections (SESIPs) across major device categories; such as safety syringes, blood collection devices, IV catheters, etc. Infection Control Today, 2009 Four Market Segments Market Opportunities Phlebotomy Pharma Intravenous Clinical
Slide The user slides a guard over the needle Snap The user snaps a guard over the needle Retractable The user activates the retraction of the needle
“A passive safety feature is one that requires no action by the user.” “Today, there are very few safety-engineered medical devices that require no active step to make a device safer during use, after use and prior to disposal.” Centers for Disease Control Infection Control Today, 2009 The Future of Safety
Vacuette® Premium Blood Collection
IV Winged Collection Set
Demonstration of operation of MedPro blood collection products compared to current market leading products
Prefilled Drug Delivery System
Hypodermic Safety Syringe
Application, Product Application Patent/Publication Title Publication or Issue Reference Number Number Date Needleless IV medical Key-Lok 09/136,478 6,146,362 11/14/2000 delivery system Automatic non-Vacu-Mate 08/632,010 5,688,241 reusable needle 11/18/1997 guard Protection device for Vacu-Mate 09/336,405 6,379,336 injection or aspiration 4/30/2002 needle Safety device for Vacu-Mate 10/289,508 6,869,415 3/22/2005 blood collection Safety system for a Vacu-Mate 10/621,973 7,357,783 blood collection 4/15/2008 device Passively guarded, Syringe Guard 10/983,108 7,198,617 fillable injection 4/3/2007 syringe Syringe guard with Syringe Guard 11/055,415 2006/0111679 selected needle 5/25/2006 configuration Syringe guard for pre-Syringe Guard 11/211,336 2007/0078403 4/5/2007 filled medicament vial Syringe Guard 11/422,851 2007/0287964 Hypodermic needle 12/13/2007 tip protector Butterfly needle with Butterfly 10/434,717 6,840,920 1/11/2005 passive guard Butterfly needle with Butterfly 10/978,614 7,144,387 12/5/2006 passive guard
Market Segment Phlebotomy Contractual Partners Targeted Networks Pharma Others Infusion Clinical
Product Expected Revenue Generation Tube Touch 2011 Skin Touch 2012 Wing 2012 Fillable 2012 Prefilled 2013
Revenue generation began Q1 2011 Guaranteed revenue totals $44 million through 2016 Completed $30 million Senior Notes offering (securitized by blood collection revenues) Current run rate = 2 years cash Strong 5 year profitability potential
160 145 Millions 140 120 in Projections 100 77 Prefilled 80 Fillable 60 Blood Collection 38.6 Revenue 40 19.5 20 3.5 8 0 2011 2012 2013 2014 2015 2016
Craig Turner › MedPro Founder, CEO and Chairman of the Board › 15 years needle technology experience; Acquired 8 passive needle technologies Walter Weller › President since 2003 › Experienced financial and operational manager Greg Schupp › COO with 20 years manufacturing and medical technology expertise Garyen Denning › Executive Vice President with over 5 years directing product development at MedPro Marc Ray › CFO with strong financial and accounting background spanning over 30 years
Craig Turner, Chairman Ernie Fletcher, Director Leo Kiely, Director Carl Kleidman, Director Gary Peterson, Director Warren Rustand, Director Walter Weller, Director
Healthcare industry experts estimate healthcare workers are routinely stuck one million times annually from exposed needles. MedPro Safety Products Inc. has solutions that virtually eliminate the risk of serious bloodborne diseases during the use of “sharps” devices. Our ergonomic, automatic, patented designs are cost-effective and easy to use. A clear competitive advantage over existing solutions, MedPro delivers a long awaited solution to all stakeholders across the continuum of care.
Addressing $3 Billion Market Opportunity Strategic Partnerships with Industry Leaders Strong Product Pipeline Unique IP Portfolio Proven Management Team